Natixis’s CVS Health CVS Stock Holding History

Natixis’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-216	Closed	-$21K	–	1144
2022 Q3	$21K	Sell	216 -49	-18%	-$4.85K	﹤0.01%	1023
2022 Q2	$25K	Buy	+265	New	+$25.9K	﹤0.01%	1086

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Natixis's CVS Position: Q1 2026 in Review

Natixis reduced its CVS Health (CVS) stake by 22% in Q1 2026, selling an estimated $6.03M and leaving 277,825 shares worth $20M. The position accounts for 0.07% of the portfolio, ranked #193.

Natixis first reported a position in CVS in Q3 2013 and has held it in 45 quarters since. The position peaked at $146M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Natixis held 277,825 shares of CVS Health worth $20M as of Q1 2026.
Natixis sold 78,316 CVS Health shares in Q1 2026, an estimated $6.03M.
CVS Health made up 0.07% of Natixis's portfolio in Q1 2026, its #193 holding.
Natixis first reported a position in CVS Health in Q3 2013 and has held it in 45 quarters since.
Natixis's CVS Health position peaked at $146M in Q3 2018.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.